Vitamin D status and the risk of pancreatic cancer: A meta-analysis

Chinese Medical Journal

Volumn 126, Issue 17, 2013, Pages 3356-3359

  Liu, Shang Long ^a   Zhao, Yu Pei ^a   Dai, Meng Hua ^a   You, Lei ^a   Wen, Zhang ^a   Xu, Jian Wei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Meta analysis; Pancreatic cancer; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ARTICLE; BIBLIOGRAPHIC DATABASE; CANCER RISK; GENETIC HETEROGENEITY; HUMAN; META ANALYSIS; MORBIDITY; MULTICENTER STUDY (TOPIC); PANCREAS CANCER; PUBLISHING; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

HUMANS; PANCREATIC NEOPLASMS; RISK FACTORS; VITAMIN D;

EID: 84883530188     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20122850     Document Type: Article

References (26)

1. Bulathsinghala P, Syrigos KN, Saif MW. Role of vitamin D in the prevention of pancreatic cancer. J Nutr Metab 2010; 2010: 721365.
2. Chen TC, Holick MF. Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab 2003; 14: 423-430.
3. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980; 9: 227-231.
4. Grant WB. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? an examination using Hill's criteria for causality. Dermatoendocrinol 2009; 1: 17-24.
5. International Agency for Research on Cancer (IARC). Chlorinated drinking-water; chlorination by-products; some other halogenated compounds; cobalt and cobalt compounds. IARC Working Group, Lyon, 12-19 June 1990. IARC Monogr Eval Carcinog Risks Hum 1991; 52: 1-544.
6. Gilbert R, Martin RM, Beynon R, Harris R, Savovic J, Zuccolo L, et al. Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis. Cancer Causes Control 2011; 22: 319-340.
7. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 2010; 46: 2196-2205.
8. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: serum vitamin D and colorectal adenoma risk. Prev Med 2011; 53: 10-16.
9. Clary B. Does vitamin D reduce pancreatic cancer risk? Two studies differ in their findings; smoking is seen as a risk factor. Duke Med Health News 2007; 13: 9.
10. Zelen M. The analysis of several 2×2 contingency tables. Biometrika 1971; 58: 129-137.
11. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
12. Grant WB. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer 2007; 120: 1123-1128.
13. Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC. Ultraviolet B irradiance and vitamin D status are inversely associated with incidence rates of pancreatic cancer worldwide. Pancreas 2010; 39: 669-674.
14. Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, Hartge P, et al. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010; 172: 10-20.
15. Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J, et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 2006; 66: 10213-10219.
16. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010; 172: 81-93.
17. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D. Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res 2012; 72: 1190-1198.
18. Wolpin BM, Ng K, Bao Y, Kraft P, Stampfer MJ, Michaud DS, et al. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2012; 21: 82-91.
19. Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS. Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer 2010; 102: 1422-1427.
20. Lindelöf B, Krynitz B, Ayoubi S, Martschin C, Wiegleb-Edström D, Wiklund K. Previous extensive sun exposure and subsequent vitamin D production in patients with basal cell carcinoma of the skin, has no protective effect on internal cancers. Eur J Cancer 2012; 48: 1154-1158.
21. Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res 2009; 69: 1439-1447.
22. Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 2006; 15: 1688-1695.
23. Zablotska LB, Gong Z, Wang F, Holly EA, Bracci PM. Vitamin D, calcium, and retinol intake, and pancreatic cancer in a population-based case-control study in the San Francisco Bay area. Cancer Causes Control 2011; 22: 91-100.
24. Stolzenberg-Solomon RZ. Vitamin D and pancreatic cancer. Ann Epidemiol 2009; 19: 89-95.
25. Chiang KC, Chen TC. Vitamin D for the prevention and treatment of pancreatic cancer. World J Gastroenterol 2009; 15: 3349-3354.
26. Woloszynska-Read A, Johnson CS, Trump DL. Vitamin D and cancer: clinical aspects. Best Pract Res Clin Endocrinol Metab 2011; 25: 605-615.